JinekM, ChylinskiK, FonfaraI, et al.A programmable dual-RNA–guided DNA endonuclease in adaptive bacterial immunity. Science, 2012; 337:816.
2.
LekA, MaK, WoodmanK, et al.Nuclease-deficient clustered regularly interspaced short palindromic repeat-based approaches for in vitro and in vivo gene activation. Hum Gene Ther, 2021; 32:260–274.
3.
DasguptaI, FlotteTR, KeelerAM. CRISPR/Cas-dependent and nuclease-free in vivo therapeutic gene editing. Hum Gene Ther, 2021; 32:275–293.
4.
QuinnJ, MusaA, KantorA, et al.Genome-editing strategies for treating human retinal degenerations. Hum Gene Ther, 2021; 32:247–259.
5.
ZhangQ-S, TiyaboonchaiA, NygaardS, et al.Induced liver regeneration enhances CRISPR/Cas9-mediated gene repair in tyrosinemia type 1. Hum Gene Ther, 2021; 32:294–301.
6.
LiF, ZhouC, TuT, et al.Rational selection of CRISPR-Cas triggering homology-directed repair in human cells. Hum Gene Ther, 2021; 32:302–309.
